Cardiac arrests among the young increase by over 25% in Israel after COVID vaccine rollout: study – LifeSite
A study of data from Israel published April 28 by Scientific Reports and Nature magazine showed a strong correlation between a more than 25% increase in heart-related emergency calls for ages 16 to 39 and the nation’s COVID-19 experimental vaccination campaign.
The peer-reviewed study was conducted by professor Retsef Levi and postdoctoral fellow Christopher Sun, both from the Massachusetts Institute of Technology (MIT), with help from Eli Jaffe of Israel’s ambulance service, Magen David Adom (MADA).
The authors analyzed MADA data from 2019 to 2021 concerning emergency calls for this younger age group “with potential factors including COVID-19 infection and vaccination rates.”
Evaluating emergency call codes for cardiac arrest (CA) or acute coronary syndrome (ACS) over the time period of January 2019 through June 2021, they were able to “to study how CA and ACS call counts change over time with different background conditions and potentially highlight factors that are associated with the observed temporal changes.”
Thus, they could observe these trends in the roughly 14 months before the COVID-19 pandemic (1/2019 – 2/2020), the 10 months of the first two waves of the supposed pandemic (3/2020 – 12/2020), and the period of an alleged third wave along with the experimental COVID-19 mRNA vaccine campaign in Israel (1/2021 – 6/2021), which employed, almost exclusively, the Pfizer injections.
The researchers found a statistically significant increase of 25.7% for CA and 26% for ACS in this younger age bracket during the period of January through May 2021 in comparison with the same period in 2020.
Furthermore, “weekly emergency call counts were significantly associated with the rates of 1st and 2nd vaccine doses administered to this age group but were not with COVID-19 infection rates,” the authors wrote.